Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

NCT00066248

Conditions
Astrocytoma, Blast Crisis, Body Weight, +83 more
Locations
  • CCOP - Bay Area Tumor Institute Oakland, California, United States
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
View all 43 locations
View Trial Details
Completed

Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab

NCT01707628

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations
  • Canisius Wilhelmina Hospital Nijmegen, Gelderland, Netherlands
  • Onze Lieve Vrouwen Gasthuis Amsterdam, North Holland, Netherlands
  • Medisch Spectrum Twente Enschede, Overrijssel, Netherlands
  • Medisch Centrum Leeuwarden Leeuwarden, Provincie Friesland, Netherlands
View Trial Details
Completed

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

NCT01273090

Conditions
Astrocytoma, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +58 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 23 locations
View Trial Details
Completed

Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma

NCT00978523

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • TGen Clinical Research Services at Scottsdale Healthcare Scottsdale, Arizona, United States
  • The Ohio State University - Comprehensive Cancer Center Columbus, Ohio, United States
  • Royal Marsden Hospital Sutton, Surrey, United Kingdom
View Trial Details
Completed

Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT00070447

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
View all 87 locations
View Trial Details
Completed

Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma

NCT01037478

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +7 more
Locations
  • Fakultní nemocnice Brno Brno, Czechia
  • Fakultní nemocnice Hradec Kralové Hradec Kralové, Czechia
  • Fakultní nemocnice Kralovske Vinohrady Prague, Czechia
  • Uniwersyteckie Centrum Kliniczne Gdansk, Poland
View Trial Details

Related conditions